ANALYSIS: November sees notable approvals – more new entrants in stroke, Alzheimer's Dx and breast tomosynthesis markets?
This article was originally published in Clinica
Executive Summary
With the recent approval of new products that will change the face of the TAVI and heart pump markets, Clinica takes a look at what other significant technologies could become available soon, and how these might affect other sectors of the medtech industry